expectations regarding our mobile applications, market acceptance, user experience, customer retention, brand development, our ability to invest and generate a return on any such investment, customer acquisition costs, operating efficiencies and leverage (including our fulfillment capabilities), the effect of any pricing decisions, changes in our product or offering mix, the timing and market acceptance of any new products or offerings, the success of our business model, our market opportunity, our ability to scale our business, the growth of certain of our specialties, our ability to innovate on and expand the scope of our offerings and experiences, our ability to reinvest into the customer experience, and our ability to comply with the extensive, complex and evolving regulatory requirements applicable to our business, including without limitation state and federal healthcare, privacy and consumer protection laws and regulations
Its important to remember that individual responses to Semaglutide may vary, and our healthcare provider will monitor your progress and adjust your treatment plan as needed
P = 0.02) (252) and the SELECT trial with semaglutide (HR 0.81
Patients should be aware that Novo Nordisk is the only company in the U.S
For non-serious reactions, consult your prescriber before making any changes to your treatment regimen
